Evidence map›Paper›PMID 24828528›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Complexity of metastasis-associated SDF-1 ligand signaling in breast cancer stem cells.

Nicholas A Graham, Thomas G Graeber

Open access · bronzeAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nicholas A GrahamDepartment of Molecular and Medical Pharmacology,Crump Institute for Molecular Imaging.
Thomas G GraeberDepartment of Molecular and Medical Pharmacology,Crump Institute for Molecular Imaging,University of California at Los Angeles Metabolomics and Proteomics Center,Jonsson Comprehensive Cancer Center, andCalifornia NanoSystems Institute, University of California, Los Angeles, CA 90095 tgraeber@mednet.ucla.edu.
University of Colorado Cancer Center · US

Funding

TARGETED COMBINATORIAL TREATMENT OF BRAF MELANOMASP01CA168585 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RIBAS, ANTONI · 2013 to 2017
$8.4M
UCLA Scholars in Oncologic Molecular lmaging (SOMI)R25CA098010 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PHELPS, MICHAEL E · 2003 to 2013
$5.0M
Diagnosing Emergence of Kinase Inhibitor Resistance on a MicrochipR21CA169993 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRAEBER, THOMAS G · 2012 to 2013
$356k
NCI NIH HHS P01 CA168585NCI NIH HHS R21 CA169993NCI NIH HHS R25 CA098010NCI NIH HHS R25T CA098010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBreast NeoplasmsChemokine CXCL12Feedback, PhysiologicalFemaleHumansNeoplasm MetastasisNeoplastic Stem CellsReceptors, CXCR4Signal TransductionChemokine CXCL12CXCR4 protein, humanReceptors, CXCR4

Identifiers

PMID24828528
PMCPMC4040584
OpenAlexW2032022925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.